Drug application
UCEPHAN (SODIUM BENZOATE, SODIUM PHENYLACETATE)
Drugs@FDA NDA 019530 · B BRAUN
Key facts
| Drug name | UCEPHAN |
|---|---|
| Active ingredients | SODIUM BENZOATE, SODIUM PHENYLACETATE |
| Application type | NDA |
| Application number | 019530 |
| Company | B BRAUN |
| Dosage forms | SOLUTION, ORAL |
| Strength | 100MG/ML;100MG/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 1 - New Molecular Entity and Type 4 - New Combination |
| Latest submission status date | Dec 23, 1987 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.